Skip to content

effect of dexmedetomidine on neuronal markers in patients undergoing aneurysmal clipping surgery

Effect of dexmedetomidine on neuronal apoptosis markers in patients with subarachnoid haemorrhage undergoing surgery in comparison to placebo: a randomised clinical control trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034762
Enrollment
50
Registered
2021-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: DEXMEDETOMIDINE: DEXMEDETOMIDINE GROUP WILL RECEIVE AN INFUSION OF 0.4 MCG/KG/HOUR AFTER A BOLUS OF 0.5MCG/KG INTRAOPERATIVELY AND UPTO 24 HOURS IN THE POST OPERATIVE PERIOD APRT FROM T

Sponsors

AIIMS BHUBANESWAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria will be all patients within 19 to 70 years of age in either sex presenting to this hospital with diagnosis of aneurysmal SAH by clinical and radiological investigations planned for surgical clipping.

Exclusion criteria

Exclusion criteria: 1) Hemodynamic instability (SBP Heart failure class III or IV (New York Heart Association) 2) Renal failure 3) Liver failure (serum protein 5 mg/dL 4) Known or suspected brain death 5) Pregnancy 6) Unable to receive dexmedetomidine within 4 hours of surgery

Design outcomes

Primary

MeasureTime frame
1) Levels of apoptotic markers( caspase 3) at 24 hours in the postoperative periodTimepoint: 24 HOURS IN THE POSTOPERATIVE PERIOD

Secondary

MeasureTime frame
1) Neurological outcomes in terms of Glasgow outcome scale at the time of discharge 2) Cognition function at the time of discharge in terms of MMSE Timepoint: TIME OF DISCHARGE ( when the clinician feels fit to dicahrge from hospital ) 1 week to 4 weeks

Countries

India

Contacts

Public ContactNitasha Mishra

AIIMS, Bhubaneswar

nitsmishra@gmail.com08373938016

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026